Literature DB >> 15702232

Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux.

Takao Itoi1, Akihiko Tsuchida, Fumihide Itokawa, Atsushi Sofuni, Toshio Kurihara, Takayoshi Tsuchiya, Fuminori Moriyasu, Kazuhiko Kasuya, Hiromi Serizawa.   

Abstract

Recent studies have suggested that pancreatobiliary reflux occurs not only in patients with pancreaticobiliary maljunction (PBM), but also in patients without PBM and thereby possibly causes biliary tract disease. In this study, we examined prospectively histological findings and genetic analysis in the non-cancerous epithelium of the gallbladder in patients with high biliary amylase levels and a normal pancreaticobiliary junction. Ki-67 L.I of non-cancerous epithelium was 14.4 and 3.5% in the high biliary amylase levels (HBA) group and the low biliary amylase levels (LBA) group, respectively (p<0.01). There was no case showing p53 overexpression regardless of amylase levels of bile. COX-2 expression was detected in the cytoplasm of non-cancerous epithelium in 9 cases in the HBA group and 5 cases in the LBA group. The positive rate of COX-2 overexpression was significantly higher in the HBA group than in the LBA group (p<0.05). COX-2 overexpression cases showed higher Ki-67 L.I than COX-2 non-overexpression cases (21.2 vs. 7.9%, p<0.05). Mutations of the K-ras gene were detected in non-cancerous gallbladder epithelium in 3 cases, only in the HBA group. Patterns of K-ras mutation at codon 12 were GAT in two cases and GTT in one case. Three cases showing COX-2 overexpression also showed K-ras mutation. These three cases showing K-ras mutation had comparatively high cellular proliferative activity (28, 26 and 14%). In conclusion, our data suggest that occult pancreaticobiliary reflux, especially with high biliary amylase levels, represents an important risk factor for the development of gallbladder carcinoma as well as PBM, and it may be possible to detect patients with such high biliary amylase levels by ERCP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702232

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

Review 1.  Pancreaticobiliary reflux in patients with a normal pancreaticobiliary junction: Pathologic implications.

Authors:  Marcelo A Beltrán
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

Review 2.  Biliary carcinogenesis in pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Sawako Kuruma; Kazuro Chiba; Taku Tabata; Satomi Koizumi; Masataka Kikuyama
Journal:  J Gastroenterol       Date:  2016-10-04       Impact factor: 7.527

3.  Pancreaticobiliary reflux in patients with and without cholelithiasis: is it a normal phenomenon?

Authors:  Marcelo A Beltrán; Mario A Contreras; Karina S Cruces
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

4.  Precancerous Pyloric Gland Metaplasia in the Biliary Epithelium Associated with Congenital Biliary Dilatation in a Three-Month-Old Infant.

Authors:  Shuichi Takano; Toshimichi Hasegawa; Kohga Masuda; Takehiko Hanaki; Naruo Tokuyasu; Teruhisa Sakamoto; Kanae Nosaka; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2022-01-21       Impact factor: 1.641

5.  Amylase levels in bile in patients with a morphologically normal pancreaticobiliary ductal arrangement.

Authors:  Jun Horaguchi; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Kei Ito; Osamu Takasawa; Takashi Obana; Takuro Endo; Kazunari Nakahara; Kazuhiko Ishida; Makoto Yonechi; Dai Hirasawa; Takashi Suzuki; Toshiki Sugawara; Tetuya Ohhira; Kengo Onochi; Yoshihiro Harada
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

Review 6.  Choledochocele associated with superficial spreading cancer with cholesterolosis of the bile duct.

Authors:  Jun Horaguchi; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Kei Ito; Osamu Takasawa; Takashi Obana; Takuro Endo; Kazunari Nakahara; Hiroshi Honda
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

7.  Pancreatobiliary reflux in individuals with a normal pancreaticobiliary junction: a prospective multicenter study.

Authors:  Jun Horaguchi; Naotaka Fujita; Terumi Kamisawa; Goro Honda; Kazuo Chijiiwa; Hiroyuki Maguchi; Masao Tanaka; Mitsuo Shimada; Yoshinori Igarashi; Kazuo Inui; Keiji Hanada; Takao Itoi; Yoshinori Hamada; Tsugumichi Koshinaga; Hideki Fujii; Naoto Urushihara; Hisami Ando
Journal:  J Gastroenterol       Date:  2013-06-05       Impact factor: 7.527

8.  Secretin-stimulating MRCP in patients with pancreatobiliary maljunction and occult pancreatobiliary reflux: direct demonstration of pancreatobiliary reflux.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Tsutomu Araki; Fumiaki Kitahara; Tadashi Sato; Jun Itakura; Hideki Fujii
Journal:  Eur Radiol       Date:  2007-04-20       Impact factor: 5.315

9.  A case of occult pancreaticobiliary reflux due to endoscopically confirmed relaxation of the Oddi sphincter.

Authors:  Fumiya Kataoka; Shin Miura; Kiyoshi Kume; Kazuhiro Kikuta; Shin Hamada; Tetsuya Takikawa; Ryotaro Matsumoto; Mio Ikeda; Takanori Sano; Akira Sasaki; Atsushi Masamune
Journal:  DEN open       Date:  2022-09-26

10.  Altered expression levels of occludin, claudin-1 and myosin light chain kinase in the common bile duct of pediatric patients with pancreaticobiliary maljunction.

Authors:  Shun-Gen Huang; Wan-Liang Guo; Zhi-Cheng Zhou; Jun-Jie Li; Fu-Bin Yang; Jian Wang
Journal:  BMC Gastroenterol       Date:  2016-01-16       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.